New research indicates that patients who discontinue blockbuster slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who end traditional diet and exercise regimens.
Research printed in a leading health publication shows that while obese individuals frequently drop substantial amounts of their total mass while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month after stopping.
"Individuals using such treatments must be aware of the potential of rapid rebound weight gain when the treatment is stopped," cautioned expert Dr. Susan Jebb.
That rate of recovery implies a return to pre-treatment mass in about one and a half years.
Weighing Therapies
The analysis, which reviewed dozens of studies involving thousands of participants, contrasted the results of these new drugs with other pills.
The team note that individuals who shed pounds through diet and exercise typically have a less rapid weight regain—approximately 100 grams monthly—post-intervention.
The Reason for the Rapid Rebound
Experts believe the mechanism of the jabs explains the amplified regain.
GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural GLP-1, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics expert.
"Stopping of this medication means appetite is no longer kept in check, making overeating much more probable."
A Chronic Issue?
Health authorities advise the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
Many experts contend that, considering the high risk of relapse, the therapy is often life-long.
This view is reinforced by pharmaceutical companies, who note that the findings "highlight the persistent nature of excess weight," akin to managing conditions like hypertension.
Patient Testimonies
Users who have discontinued the jabs explain a sudden return of appetite.
"I experienced a trigger flipping and you become starving," recalled one woman.
This challenge is exacerbated if patients have not adopted permanent dietary or behavioural modifications during treatment.
Significant Adoption
Survey data suggest that millions of adults in the UK have used these injections in the past year, with interest remaining high.
- Use is more common among females than men.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
In conclusion, researchers stress that while GLP-1 drugs are powerful tools for shedding pounds, they are not a permanent solution and maintained weight loss hinges on combined lifestyle management.